ACET vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

ACET

37.6
AI Score
VS
ACET Wins

CLOV

34.3
AI Score

Investment Advisor Scores

ACET

38score
Recommendation
SELL

CLOV

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACET CLOV Winner
Net Income -41.60M -85.55M ACET
Operating Income -43.87M -85.53M ACET
ROE -34.6% -27.7% CLOV
ROA -28.1% -15.8% CLOV
Total Assets 148.17M 541.01M CLOV
Cash 33.13M 78.30M CLOV
Current Ratio 6.71 1.47 ACET
Free Cash Flow -41.55M -68.98M ACET

Relative Price Performance (Last 90 Days)

ACET 1M: +9.1% · 3M: +16.5% CLOV 1M: -8.8% · 3M: +15.3%

Current Technical Phase

ACET

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.4% over 20 days), RSI 58

RSI (14): 58.4 · Price: $9.19

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $4.15

Fundamentals Snapshot

Metric ACET CLOV
Market Cap
Forward P/E -2.3 27.7
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.6%
Gross Margin 0.2%
Operating Margin 0.0% 0.0%
EPS -10.42 -0.05
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ACET is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.